Reshmi Srinath, director of the Weight and Metabolism Management Program at NYU Langone Health, emphasizes that there is no rigorous scientific evidence supporting microdosing approaches
What are the main side effects of tirzepatide, and how do they compare to GLP-1
Each of these mechanisms helps make it easier to control your eating habits and lose weight
Improves Metabolic and Cardiovascular Biomarkers: Treatment results in lower blood pressure, improved insulin sensitivity, reduced triglycerides and non-HDL cholesterol, and favorable changes in adiponectin and leptin, all contributing to cardiovascular and metabolic benefits 1,4
Phase 3 readouts are landing on a rolling basis, but FDA approval has not happened as of June 2026
There's no reason to stop GHK-Cu because of semaglutide-related nausea